Stock Value
Competitors
| Ticker | Price | Forecast 1Y | Forecast 2Y | Market Cap | Div Yld | Growth Rate |
|---|---|---|---|---|---|---|
|
NYSE:LLY
Eli Lilly and
|
734.97 | -46.29% | -24.25% | 661,770.95 | 0.69% | 2.63% |
|
NYSE:JNJ
Johnson & Johnson
|
149.27 | 0% | 0% | 359,245 | 3.31% | 2.71% |
|
NYSE:MRK
Merck
|
127.51 | -7.42% | 6.15% | 322,986.42 | 2.4% | -19.03% |
|
LSE:AZN
AstraZeneca PLC
|
120.50 | 19.51% | 42.34% | 186,803.32 | 2.04% | 15.98% |
|
SWX:NOVN
Novartis
|
87.97 | 14.79% | 28.98% | 179,494.55 | 3.71% | 4.67% |
|
SWX:ROG
Roche Holding
|
217.30 | 36.77% | 53.45% | 175,193.12 | 4.48% | 0.43% |
|
NYSE:PFE
Pfizer
|
27.81 | 11.74% | 42.95% | 157,475.27 | 6.06% | -9.31% |
|
NasdaqGS:AMGN
Amgen
|
311.29 | -11.89% | -3.07% | 166,968.34 | 3.23% | 5.31% |
|
ENXTPA:SAN
Sanofi
|
91.30 | 16.54% | 35.07% | 114,001.35 | 4.09% | 8.19% |
|
LSE:GSK
GSK
|
17.34 | 9.98% | 26.18% | 70,692.55 | 3.36% | 0.79% |
|
NYSE:BMY
Bristol-Myers Squibb
|
43.99 | 61.89% | 72.23% | 89,172.13 | 5.49% | 13.54% |
|
NasdaqGS:GILD
Gilead Sciences Inc
|
64.78 | 26.38% | 36.06% | 80,778.67 | 4.71% | 0.15% |
|
XTRA:MRK
Merck KGaA
|
152.00 | 13.25% | 29.47% | 66,086.24 | 1.46% | 10.29% |
|
TSE:4568
Daiichi Sankyo Company
|
5502.00 | 0% | 0% | 10,550,099.8 | 1.09% | 0% |
|
TSE:4502
Takeda Pharmaceutical Company
|
4125.00 | 0% | 0% | 6,471,852.14 | 4.56% | 0% |
|
NasdaqGS:BIIB
Biogen
|
217.51 | -10.14% | 5.81% | 31,668.78 | 0% | -10.89% |
|
XTRA:BAYN
Bayer
|
28.02 | 70.88% | 87.56% | 27,527.52 | 0.39% | 1.47% |
|
NasdaqGS:BNTX
BioNTech
|
92.72 | 0% | 0% | 22,344.64 | 0% | 2,408.98% |
|
NasdaqGS:ALNY
Alnylam Pharmaceuticals Inc
|
152.33 | 0% | 0% | 19,268.49 | 0% | 0% |
|
TSE:4503
Astellas Pharma
|
1558.00 | 0% | 0% | 2,793,472.85 | 4.75% | 0% |
